Massimo Claudio Fantini

15PUBLICATIONS
67CO-AUTHORS
Innate immunityMedical biochemistry - proteins and peptides (incl. medical proteomics)Rheumatology and arthritisNutrigenomics and personalised nutritionFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 28, 2026
Patients with Crohn's Disease Achieving Ustekinumab-Induced Remission Are Characterized by Increased Baseline IL-23 Receptor Expression on Lamina Propria Th1 Cells.

|Jul 24, 2026
Pancreatic Hyperenzymemia in Inflammatory Bowel Disease: Clinical Characterization and Outcomes from the European PANDORA Registry.

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

|Feb 13, 2026
Optimizing Malnutrition Risk Detection in Inflammatory Bowel Disease: A Longitudinal Analysis of Serial Nutritional Screening Tools.

Agnese Favale, Valentina Orrù, Nicola Lutzu

|Nov 13, 2025
The Importance of Treatment Timing and Positioning in IBD.

Giulia Valdiserra, Massimo C Fantini, Agnese Favale

|Oct 22, 2025
Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease.

Amalia Di Petrillo, Antonella Fais, Nicola Raho

Pageof 3

Frequent Collaborators

4 joint publications

Stefano Festa

4 joint publications

Daniela Pugliese

4 joint publications

Edoardo Vincenzo Savarino

4 joint publications

Agnese Favale